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LETTER TO THE EDITOR
Resuscitation in COVID-19 patients:  
What do we know and what should we do?
Ezgi Yilmaz, Ethem Murat Arsava, Mehmet Akif Topcuoglu
Hacettepe University Hospitals, Neurological Intensive Care Unit, Sıhhiye, Ankara, Turkey
Recent articles on cardiopulmonary resusci-
tation (CPR) in coronavirus disease 2019 (COV-
ID-19) patients [1, 2] were read with great interest.
It was concurred herein, that automated chest 
compression devices (ACCD) should be added to 
cardiopulmonary resuscitation (CPR) protocols in 
pandemic and these data are welcomed [1]. How-
ever, presently it was not considered right to leave 
the decision of CPR for the elderly with initial non-
shockable rhythms to individual therapeutic teams 
[2]. In addition to a self-fulfilling prophecy risk, the 
effect of self-protection behavior of decision mak-
ers on the decision-making process may create less 
aggressive medical management risk than it should 
be. The present article discusses both strategies 
proposed for the CPR decision and management 
after the return of spontaneous circulation.
Resistant hypoxemia secondary to viral pneu-
monia associated acute respiratory distress syn-
drome, primary viral or secondary myocardial 
injury, serious ventricular arrhythmias, and shock 
are considered among the leading reasons of in-
hospital cardiac arrest and the resulting mortality 
[3]. In patients diagnosed with or suspected to have 
COVID-19, CPR poses a certain risk to healthcare 
professionals due to excessive air droplet scatter-
ing (aerosolization) during the procedure.
Reports during the pandemic period have indi-
cated that the survival rate after CPR is lower and 
the neurological prognosis is worse in COVID-19 
cases, in comparison to a non-pandemic era [4]. 
Reasons may include admission of patients with 
severe COVID-19 to regular floor beds due to the 
scarcity of intensive care beds and high ventilator 
occupancy, a delay in initiation of resuscitation 
due to time lost while wearing personal protective 
equipment, suboptimal quality of resuscitation, 
and a more predominant role of respiratory failure 
as the cause of arrest. Moreover, the prevalence 
of out-of-hospital cardiac arrest (OHCA) has also 
increased during the pandemic [5]. Rates of not 
only survival but also favorable prognosis have 
deteriorated in OHCA compared to the previous 
data, probably due to prolonged transport time of 
patients to hospitals and lower rate of resuscitation 
by lay persons at the scene.
The general principles of the recent resuscita-
tion guidelines in pandemic, which highlight certain 
algorithmic adaptations to enhance the protection 
of the resuscitator during basic/advanced cardiovas-
cular life support, are noteworthy. However, it is not 
known whether these adaptations would positively 
or negatively affect the survival rates observed after 
CPR in this era. In addition, there are insufficient 
data to support the use of extracorporeal CPR and 
targeted temperature management in COVID-19 
patients. It is also known that induced hypother-
mia in severe sepsis is potentially harmful [6], 
and considering that these invasive methods are not 
widely applicable, it can be predicted that COVID-19 
CPR survivors will not be amenable for these thera-
pies in the current global resource-limiting setting.
As for all post-CPR patients, in comatose 
COVID-19 survivors, one of the main critical issues 
is the determination of neurological prognosis after 
the return of spontaneous circulation. However, 
recent interim guidelines do not address this issue. 
The present article shares opinions and concerns 
on neuroprognostication of patients who survived 
in a comatose state after CPR, also called as post-
resuscitation encephalopathy (PRE).
First of all, “neurological examination” is 
crucial in establishing neuroprognostication in 
COVID-19 patients with PRE [7]. In theory, 
a bed-side neurological examination will assess 
the extent of the neuro-anatomical injury to some 
degree, especially if performed by an experienced 
neurointensivist. In the examination performed 
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72 h after return of spontaneous circulation, the 
absence of pupillary reactions and no better than 
decerebrating motor response to painful stimuli 
are highly reliable prognostic markers of poor 
prognosis [8]. During this period, an absence of the 
corneal reflex, presence of up-ward eye deviation 
and myoclonic jerks are also helpful in prognos-
tification. However, in the last decade, problems 
related to performing prognostification with “only” 
neurological examination have repeatedly been 
emphasized. It is underlined that the examination 
may not be objective under confounding factors 
like hypothermia, sedation, muscle relaxants and 
hemodynamic instability, and estimations sugges-
tive of poor outcomes could inadvertently lead to 
a self-fulfilling prophecy when making individual 
decisions for the patient. The lack of blinding in 
most of the studies focusing on prognosis, very 
low sensitivity of neurologic examination findings, 
and probably the not so high specificity of these 
measures in a real-life setting, probably underlie 
the cautious statements in this regard [7]. 
At this point, it should be noted that the 
majority of post-arrest deaths is due to the ces-
sation or withdrawal of “active” of life-sustaining 
treatments, which is primarily driven by the deci-
sion of poor prognosis based on examination [7]. 
A chaotic setting like the current pandemic, might 
put more pressure on doctors experiencing diffi-
culties for booking an intensive care unit bed, and 
might force them to stop life-sustaining treatments 
earlier. However, even leaving aside the discus-
sions in the general population, it should not be 
forgotten that the accuracy of these prognostic 
models, and thereby the decisions for continuation 
or withdrawal of care, have not been investigated 
properly in COVID-19 patients. In addition, it is 
also not known how these patients would recover 
in the long run after appropriate care.
A multitude of questions are still unanswered 
regarding the prognostic models for COVID-19 pa-
tients. Could it be useful to incorporate biomarkers 
such as neuron-specific enolase, electrophysiology 
such as electroencephalographic reactivity, or 
imaging tools such as diffusion-weighted mag-
netic resonance imaging (DWI) to algorithms to 
increase the accuracy of decisions in COVID-19 
patients with PRE? Can the presence of widespread 
ischemic damage detected in DWI be performed 
between the second and fifth days after success-
ful CPR guide the prognosis [9]? Pure hypoxemia 
and global cerebral ischemia are also said to show 
different patterns in DWI, would it be helpful [10]? 
And the list goes on.
It should not be forgotten that albeit COVID-19 
might follow a serious course, it is not a terminal 
disease, most patients can be saved with good criti-
cal care support, and these patients deserve the 
standard of care during and after cardiac arrest. It is 
without doubt that we need to study neuroprognos-
tification in COVID-19 patients with PRE, within 
a short time and without further delay. Until this is 
achieved, physicians in the front-line, need precise 
expert opinions and guidelines, as they continue to 
employ prudent decisions without swerving from 
scientific principles, as always. 
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